ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere”) – a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – announced today that Richard Faleschini, president and chief executive officer, is scheduled to present at the 28th Annual Canaccord Adams Global Growth Conference on Thursday, August 14th, at 2:00 p.m. ET. The conference will be held at the InterContinental in Boston, Massachusetts, from August 12-14, 2008.
